Showing results (81-90 of 219) with videos related to

Sort By:
Pageof 22
European Journal of Immunology|May 16, 2012
CD4+ T-cell immunity after pandemic influenza vaccination cross-reacts with seasonal antigens and functionally differs from active influenza infectionTina Schmidt, Jan Dirks, Martin Enders, et al.
Tropical Medicine & International Health : TM & IH|November 8, 2012
Unrecognised tuberculosis at antiretroviral therapy initiation is associated with lower CD4+ T cell recoverySabine M Hermans, Frank van Leth, Agnes N Kiragga, et al.
Frontiers in Immunology|February 11, 2021
Case Report: Management of a Multidrug-Resistant CMV-Strain in a Renal Transplant Recipient by High-Dose CMV-Specific Immunoglobulins, Modulation in Immunosuppression, and Induction of CMV-Specific Cellular ImmunityVanessa Wiening, Tina Schmidt, Maximilian Dahmen, et al.
Antiviral Therapy|February 21, 2013
Risk of tuberculosis after antiretroviral treatment initiation: a comparison between efavirenz and nevirapine using inverse probability weightingSabine M Hermans, Yukari C Manabe, Agnes N Kiragga, et al.
Antiviral Therapy|November 13, 2004
Quality of life in patients treated with first-line antiretroviral therapy containing nevirapine and/or efavirenzFrank van Leth, Brian Conway, Hector Laplumé, et al.
Peerj|September 17, 2019
Bridging the TB data gap: <i>in silico</i> extraction of rifampicin-resistant tuberculosis diagnostic test results from whole genome sequence dataKamela C S Ng, Jean Claude S Ngabonziza, Pauline Lempens, et al.
The Journal of Infectious Diseases|May 7, 2002
Age-related decrease in adenovirus-specific T cell responsesMartina Sester, Urban Sester, Susana Alarcon Salvador, et al.
Plos One|September 17, 2013
Antigen-specific CD4 T cells are induced after intravesical BCG-instillation therapy in patients with bladder cancer and show similar cytokine profiles as in active tuberculosisJulia Elsäßer, Martin W Janssen, Frank Becker, et al.
Trials|August 17, 2014
A multicenter, randomized, open-labeled study to steer immunosuppressive and antiviral therapy by measurement of virus (CMV, ADV, HSV)-specific T cells in addition to determination of trough levels of immunosuppressants in pediatric kidney allograft recipients (IVIST01-trial): study protocol for a randomized controlled trialThurid Ahlenstiel-Grunow, Armin Koch, Anika Großhennig, et al.
Transplantation Direct|November 10, 2025
The Role of Cytomegalovirus-specific Immunoglobulins as Modulators of Antigen-specific T-cell Expansion In VitroAmina Abu-Omar, Saskia Bronder, Janine Mihm, et al.
Pageof 22